Abstract
INTRODUCTION
Despite the recent progress in neoadjuvant chemotherapy and definite chemoradiotherapy for thoracic oesophageal squamous carcinoma (ESC), oesophagectomy or more recently endoscopic mucosa resection for early stage disease has been utilized whenever feasible. However, even following curative surgery such as thoracic oesophagectomy and three-field lymphadenectomy, regional lymph node recurrence or distant haematogenous recurrence, indicative of microscopic lymphatic and/or vascular invasion, is still common, and its occurrence should be monitored by surgeons, oncologists and pathologists.
Our previous study [1] established the adverse effect of lymphatic or vascular invasion on the survival of patients with thoracic ESC after radical surgery and determined that lymphatic invasion was an independent predictor of poor prognosis in early stage disease. Since lymphatic invasion and vascular invasion are 2 different but interrelated entities with similar incidence and prognosis, we believe that it is inadequate to separately discuss the prognostic impact of either lymphatic or vascular invasion. We hypothesize that there is a cumulative influence of lymphovascular invasion on prognosis and surgical oncologic outcomes that has not been fully illustrated in the literature.
The present study demonstrated the status of lymphovascular invasion in surgical specimens removed by radical operation for thoracic ESC and focused on the cumulative impact of simultaneous lymphatic and vascular invasion on †The first two authors contributed equally to this paper.
surgical oncologic outcomes compared with that of lymphatic or vascular invasion alone.
MATERIALS AND METHODS

Patients and surgical considerations
We made computerized and manual searches using the keywords 'Ivor-Lewis procedure' OR 'McKeown procedure' AND 'R0 resection' AND 'thoracic oesophageal squamous carcinoma' in our hospital database; the patients whose tumour was pathologically confirmed as 'tumour in situ' were excluded. The patients who have received preoperative neoadjuvant chemotherapy and/or radiotherapy were also excluded. Thus, the 598 remaining cases (17 cases of Ivor-Lewis procedure and 581 cases of McKeown procedure) of curative open en bloc oesophagectomy plus at least mediastinal (including lymph nodes along bilateral recurrent laryngeal nerves) and abdominal lymph node dissection for thoracic ESC in the period of 2002 to 2014 were included in the present study.
The preoperative workup consisted of cardiopulmonary function evaluation, computed tomography of the neck, chest and abdomen, endoscopy, and oesophagography. Endoscopic ultrasound and positron emission tomography have been administered to the patients in recent years.
The postoperative in-hospital mortality was 1.3% (8 of 598). The lymph nodes were removed from the total specimen by the surgeons after en bloc oesophagostomy. The median of the dissected lymph node was 39 ) and the median of positive lymph node was 1 (0-28). Postoperative chemotherapy consisting of 5-fluorouracil and cisplatin to reduce the risk of recurrence was prescribed to 95 patients with advanced-stage disease. The present study was approved by the Research Ethics Board, and written individual informed consent to participate in the study was waived.
Data collection
Patient data, including but not limited to demographic characteristics, such as age and gender, and disease characteristics, such as tumour location, carcinoma cell differentiation, pathological T parameter, pathological N parameter, pathological M parameter (supraclavicular lymph node metastasis), and pathological disease stage, were registered from our hospital database. The seventh edition of the Union for International Cancer Control tumour, node and metastasis classification system was employed to pathologically stage the tumours.
Lymphovascular invasion
In the current study, lymphovascular invasion included lymphatic invasion and/or vascular invasion. The presence of lymphovascular invasion was determined only when the cancer cell clusters were discovered within a vessel-like, endothelium-lined structure. Lymphatic invasion and vascular invasion were routinely distinguished by pathologists using haematoxylin and eosin (HE) staining. The method to distinguish lymphatic invasion from vascular invasion was described in our previous study [1] . Briefly, after HE staining, the presence of erythrocytes within the involved vessel lumen and the relatively large diameter of the involved vessel helped to distinguish vascular invasion from lymphatic invasion.
For the samples that were difficult to distinguish between lymphatic and vascular invasion or without definitively positive evidence of lymphovascular invasion by HE staining, podoplanin staining, which detects lymphatic endothelium, and CD34 staining, which detects vascular endothelium, were used in representative slices to better distinguish between lymphatic and vascular invasion. The status of lymphovascular invasion by HE staining and specific immunohistochemical staining was independently evaluated by 2 experienced pathologists, both of whom were blinded to the demographic information, tumour stage and long-term clinical outcome. Disagreements on the status of lymphovascular invasion were discussed and resolved through consensus.
Then, we divided the patients into 3 groups according to the status of lymphovascular invasion: (i) patients with neither lymphatic nor vascular invasion, (ii) patients with lymphatic invasion alone or vascular invasion alone and (iii) patients with simultaneous lymphatic and vascular invasion.
Follow-up
The follow-up plan and strategy were described in our previous study [1] . Briefly, all the patients underwent cervical, thoracic and abdominal computed tomography every 3-6 months for postoperative Years 1-2, every 6-12 months for postoperative Years 3-5, and then every year beyond postoperative Year 5. Upper gastrointestinography or endoscopy was performed when clinically indicated. The end-point events were postoperative disease recurrence and patient death. The data on the patients without end-point events were censored until the end of 2015. The data for the patients who did not complete follow-up were censored at the last follow-up date.
Regarding the postoperative recurrence site, the recurrence pattern was divided into loco-regional, distant and combined recurrence based on the first recurrence site confirmed in the follow-up medical record. Locoregional recurrence reflected a recurrence at an anastomotic site or in the regional lymph node, including the supraclavicular lymph node. Distant recurrence reflected a recurrence in a distant visceral organ. Combined recurrence reflected a loco-regional and distant recurrence that were diagnosed simultaneously.
Regarding the postoperative time to recurrence, the recurrence pattern was divided into early and late recurrence. Early recurrence was defined as recurrence within 12 months after surgery, while late recurrence was defined as recurrence beyond 12 months after surgery.
Statistical methods
The Statistical Package for the Social Sciences (SPSS) 19.0 (SPSS Inc., Chicago, IL, USA) was utilized for all the statistical analyses and to create relevant curves. The v 2 test was used as appropriate to evaluate the differences in proportions. Fisher's exact test was used when the data were very unequally distributed among the cell counts of the table, resulting in low cell counts being predicted by the null hypothesis. The predefined rule was applied when the expected values were below 5 in any of the cells in a contingency table. Student's t-test was used to evaluate continuous variables. Mean values and standard deviations were reported unless otherwise stated. Disease-free survival (DFS) curves were constructed using the Kaplan-Meier method and compared using the log-rank method among the demographic and clinicopathological variables such as gender, age, tumour location, tumour differentiation, status of lymphovascular invasion, the T parameter, the N parameter and the M parameter. For the status of lymphovascular invasion, DFS was further analysed using the Kaplan-Meier subset analysis. The variables with a P-value <0.1 in the univariable analysis were included in the multivariable analysis. Cox regression analysis, with a backward Wald stepwise process for including or excluding variables, was applied to establish the independent predictive factors for decreased DFS. For all statistical analyses, a P-value <0.05 was regarded as significant.
RESULTS
Clinicopathological information and prevalence of lymphovascular invasion
Demographic and clinicopathological information are listed in Table 1 . Patients with no evidence of lymphatic or vascular invasion accounted for 41.3% of the total study population. Lymphatic or vascular invasion alone was found in 35.1% of patients. Simultaneous lymphatic and vascular invasion were discovered in 23.6% of patients. The status of lymphovascular invasion was significantly associated with tumour differentiation (P = 0.045, v 2 test) and correlated with the intramural invasive depth (T parameter, P < 0.001, v 2 test), regional lymph node involvement (N parameter, P < 0.001, v 2 test), supraclavicular lymph node metastasis (M parameter, P < 0.001, Fisher's exact test) and thus tumour, node and metastasis stage (P < 0.001, v 2 test) ( Table 1) .
Disease-free survival and predictors for diseasefree survival after curative surgery There were 7 patients who did not complete the follow-up period, resulting in a follow-up rate of 98.8% (591 of 598). The median follow-up period was 42.7 months for the whole cohort. The 1-, 3-and 5-year overall survival (OS) rates and the 1-, 3-and 5-year postoperative DFS rates of the whole cohort subdivided by the status of lymphovascular invasion are listed in Table 2 . There was a significant difference in overall survival rates and DFS rates between any 2 groups (P < 0.001, Table 2 ). Univariable analysis showed that higher T parameter (P < 0.001), higher N parameter (P = 0.027), higher M parameter (P < 0.001) and the status of lymphovascular invasion (P < 0.001, Fig. 1 ) were associated to decreased postoperative DFS. Simultaneous lymphatic and vascular invasion also significantly decreased the DFS compared to lymphatic and vascular invasion alone, while lymphatic and vascular invasion alone significantly reduced DFS compared to having neither lymphatic nor vascular invasion. Then, the DFS curves were compared in a subset analysis, which demonstrated a significant reduction of DFS in pathological Stage I (P = 0.008), Stage II (P = 0.003) and Stage III (P = 0.002) patients by lymphovascular invasion (Fig. 2) .
Poor tumour differentiation was a potential factor related to decreased survival (P = 0.100, Table 3 ).
The Cox regression analysis, the efficacy of which was determined by a v 2 test (v 2 = 227.5, P < 0.001), established the roles of higher T parameter (P < 0.001, odds ratio: 1.436), higher N parameter (P < 0.001, odds ratio: 1.838) and lymphovascular invasion (P < 0.001, odds ratio: 1.568) as the independent risk factors for reduced DFS after curative surgery for thoracic ESC (see Table 3 ).
Predictive value of lymphovascular invasion for recurrence pattern
Among the 219 patients with recurrence, loco-regional recurrence, distant recurrence and combined recurrence accounted for 41.6%, 36.5% and 21.9% of cases, respectively. Tumours recurred within 1 year after surgery in 53.4% of patients with recurrence.
The recurrence pattern of the first diagnosed recurrent sites was not significantly correlated with the status of lymphovascular invasion (P > 0.05, v 2 test). The recurrence pattern regarding the time to recurrence was correlated with the status of lymphovascular invasion (P = 0.037, v 2 test; Table 2) , with significantly more patients in the simultaneous lymphatic and vascular invasion group recurring within 12 months after curative surgery.
DISCUSSION
The current study showed the greater negative impact of simultaneous lymphatic and vascular invasion on surgical oncologic outcomes than that of lymphatic or vascular invasion alone for thoracic ESC after radical oesophagectomy plus lymphadenectomy. In addition to the correlation between lymphovascular invasion and disease stage, the presence of lymphovascular invasion independently predicted decreased overall survival and DFS, with simultaneous lymphatic and vascular invasion implying poorer prognosis than lymphatic or vascular invasion alone. Despite the curability of subtotal oesophagectomy and threefield lymph node dissection, the most common recurrence pattern of thoracic ESC is regional lymph node recurrence (41.6%), followed by distant visceral organ recurrence (36.5%) even when the initial disease did not have evidence of lymph node involvement, indicating a prominent effect of microscopic lymphovascular invasion in the lesion. Previous studies of lymphovascular invasion as evaluated by HE staining suggest that tumours with lymphovascular invasion are at higher risk of recurrence and may be associated with poor prognosis in oesophageal adenocarcinoma [2] . However, whether lymphatic or vascular invasion contributes to poor prognosis remains controversial in ESC, because studies in the literature [3] [4] [5] [6] have enrolled heterogeneous patients with different tumour cell types and employed heterogeneous methods varying from HE staining, which is likely to underestimate the prevalence of lymphovascular invasion, to specific immunohistochemical staining for the detection of lymphovascular invasion. The advent of specific immunohistochemical staining for vascular endothelium (CD34) and lymphatic endothelium (podoplanin) is believed to have increased the accuracy of detecting and distinguishing the existence of vascular and lymphatic invasion in ESC [7] . The frequency of lymphatic and/or vascular invasion was 58.7% (35.1% + 23.6%) in the present study, which was higher than the studies in which lymphovascular invasion was assessed based on HE staining only [8, 9] . The efficacy of specific staining in improving the sensitivity and specificity of detecting lymphatic and vascular invasion has been discussed in the literature [10, 11] . In some difficult cases, a thin line of endothelium in a tumour cell nest may be undetectable and indistinguishable by HE staining but can be reliably detected and distinguished using specific immunohistochemical staining. We recommend the routine use of specific elastin staining in all patients with negative results of lymphovascular invasion by HE staining.
Some studies in the literature only focused on lymphatic invasion [12] or venous invasion [13] . However, in clinical medical practice, patients with lymphatic invasion are not treated differently from patients with vascular invasion due to the similar prognostic impact of lymphatic invasion and vascular invasion. We think it is appropriate to distinguish between lymphatic and vascular invasion and consider both when discussing their prognostic impact. Whether there is a cumulative impact of lymphovascular invasion on thoracic ESC has not been demonstrated in the literature. After making the distinction between lymphatic and vascular invasion, we found that patients with simultaneous lymphatic and vascular invasion had a poorer prognosis than patients with either lymphatic or vascular invasion alone and had an even worse prognosis than patients without any indication of lymphovascular invasion (Fig. 1, Table 2 ), which was consistent with the results in oesophageal adenocarcinoma study by Perry et al. [11] . Further subset analysis confirmed such effects in pathological Stage I-III in diseases (Fig. 2) . Adjuvant therapy might play a role particularly, in patients with simultaneous lymphatic and vascular invasion without nodal involvement, which should be further studied through multicentre, prospective, randomized controlled studies.
More than 50% of recurrences occurred within 12 months after surgery in the current study. A prior prospective study showed a high incidence of micrometastasis in the rib or the iliac bone [14] . We believe that many patients with early recurrence might have developed micrometastasis or macrometastasis that failed to be detected by modern imaging tools before surgery, which gradually grew after surgery. This explanation was consistent with the results in the present study that showed that lymphovascular invasion, the first step in distant metastasis, was significantly correlated with early recurrence after curative surgery. Therefore, for patients with high-risk factors of recurrence and especially those with both lymphatic and vascular invasion, active follow-up is necessary to early detect recurrence. Neoadjuvant chemotherapy or adjuvant chemotherapy may be considered in early stage diseases with aggressive simultaneous lymphatic and vascular invasion, which should be confirmed in a future prospective, randomized, controlled clinical trial.
More severe venous invasion has been demonstrated to be related with aggressive histology, poorer survival and metachronous liver metastasis in colorectal carcinoma [15, 16] . Lymphatic invasion or vascular invasion in the resected circumferential margin is supposed to be correlated with poor clinical outcomes [17, 18] . Due to constraints in time and resource, we made qualitative but not quantitative analyses of lymphovascular invasion in the current study. In our subsequent study, we intend to not only quantify the lymphovascular invasion but also take some specific characteristics of lymphovascular invasion into consideration, such as the presence or absence of lymphovascular invasion at the circumferential resected margin, embolism versus non- embolism invasion and intratumour versus paratumour lymphovascular invasion.
In the present study, we excluded patients with neoadjuvant therapy, given the fact that radiotherapy or chemoradiotherapy would obliterate tiny lymphatic channels and/or blood vessels [19, 20] , thereby possibly increasing the difficulties in evaluating the status of lymphovascular invasion. We acknowledge that many patients with regional squamous carcinoma are treated with some type of neoadjuvant therapy, yet there are many patients who undergo operation without any neoadjuvant therapy. In our subset analysis, simultaneous lymphatic and vascular invasion decreased survival in Stage I patients who may be candidates of surgery without neoadjuvant treatment. Therefore, we believe the conclusions of the present study still apply to current medical practice.
Finally, this is a single-institution retrospective study of ESC, and therefore, selective bias and statistical bias might affect the outcome. Moreover, caution should be particularly taken when extrapolating the present findings to Western countries where the dominant histological type of oesophageal carcinoma is adenocarcinoma.
CONCLUSION
Our conclusions are that lymphovascular invasion has worse surgical oncologic outcomes irrespective of disease stage, with simultaneous lymphatic and vascular invasion implying poorer prognosis than lymphatic or vascular invasion alone. Distinctions between lymphatic and vascular invasion should be routinely made. The initiatives of worldwide oesophageal cancer collaboration [21] [22] [23] [24] are appreciated, and international cooperation is necessary to further study the role of lymphovascular invasion in cancer staging and prognostication.
